Health & Science Policy | Senior Fellow @JoinFAI (Biomed Innovation) & Evidence Fellow @KelloggOx (Pandemics) | Recently @NIH |

Washington, DC
Joined July 2017
🚨 NEW: Restore Childhood just funded peer-reviewed research that improves upon the @FDA's own benefit-risk analysis of the Moderna mRNA COVID vaccine. The finding? For 18–25-year-old males, vaccine risks outweighed benefits relative to hospitalizations. Here's what made this study different, and why it matters: ✅ Incorporated benefits from prior COVID infection ✅ Used data stratified by age AND sex ✅ Multidisciplinary team: 2 mathematicians, a clinician, epidemiologist, immunologist & bioethicist This is what proper evidence-based medicine looks like. The team: mathematician Paul Bourdon, PhD, @KrugAlli @KevinBardosh, and RC board member Ram Duriseti, MD, PhD. Recently published. Peer-reviewed. Bias-free. Unfunded by industry. This is the kind of research our children deserve, and exactly why @Rstorechildhood exists. #VaccineSafety #IndependentResearch
Our new paper in @Vaccines_MDPI reanalyzes the FDA's benefit-risk assessment of Moderna's mRNA-1273 COVID vaccine (orig formulation). We focus on hospitalizations—those prevented by vaccination vs. those caused by vaccine-attibutable myocarditis/pericarditis (VAM/P). We incorporate benefits from prior COVID infection—something the FDA overlooked. Our analysis is restricted to males 18-25 (those at highest VAM/P risk). Bourdon PS, Duriseti R, Gromoll HC, Dalton DK, Bardosh K, Krug AE. A Reanalysis of the FDA’s Benefit–Risk Assessment of Moderna’s mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. Vaccines. 2026; 14(2):165. doi.org/10.3390/vaccines1402… cc @KevinBardosh 1/9
8
3
18
1,823
Kevin Bardosh retweeted
Our new paper in @Vaccines_MDPI reanalyzes the FDA's benefit-risk assessment of Moderna's mRNA-1273 COVID vaccine (orig formulation). We focus on hospitalizations—those prevented by vaccination vs. those caused by vaccine-attibutable myocarditis/pericarditis (VAM/P). We incorporate benefits from prior COVID infection—something the FDA overlooked. Our analysis is restricted to males 18-25 (those at highest VAM/P risk). Bourdon PS, Duriseti R, Gromoll HC, Dalton DK, Bardosh K, Krug AE. A Reanalysis of the FDA’s Benefit–Risk Assessment of Moderna’s mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection. Vaccines. 2026; 14(2):165. doi.org/10.3390/vaccines1402… cc @KevinBardosh 1/9
12
42
11
113
20,496
Kevin Bardosh retweeted
WATCH: Secretary Rubio Delivers Remarks to the Munich Security Conference in Munich, Germany. xitter.cf/i/broadcasts/1mnGeNNPq…
2,681
9,843
2,202
39,982
7,837,980
Kevin Bardosh retweeted
Congratulations to @KrugAlli @KevinBardosh and co-authors on this detailed reassessment of benefit-risk of one covid shot in young men with inclusion of additional variables. Clinical decisionmaking when absolute benefits and risk are both very small is one of the most challenging in medicine. Look forward to seeing more of your great work! A Reanalysis of the FDA’s Benefit–Risk Assessment of Moderna’s mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection mdpi.com/3723372 #mdpivaccines via @Vaccines_MDPI
8
9
2
33
4,486
I’ve wanted to read Milan Kundera’s The Unbearable Lightness of Being for 20 years. Finally came to it: One of the most incredible poetic plays on the themes of “lightness and weight” in human relationships - of freedom and responsibility, of the incomprehensibility of others.
11
383
A new breakthrough HIV therapy that promises to end AIDS deaths from multi-drug resistance is up for accelerated clinical development and regulatory approval at the FDA today. My latest in @EpochTimes theepochtimes.com/opinion/en…
1
4
11
1,138
A new Scientific Reports paper by @BMuellerSN et al. fundamentally challenges early claims that #COVID #lockdowns in #Germany “clearly saved lives.” By applying multiple competing statistical models instead of a single favored one, the authors show that uncertainty was massively underestimated in earlier analyses. 👉 nature.com/articles/s41598-0…
9
33
5
108
10,254
Alzheimer’s affects 7M Americans, costing $1 Trillion/yr & devastating families. My latest in @dcexaminer proposes an OWS-like model to speed-up drug development and slash trillion-dollar costs. Bold leadership from Trump Admin can do it. washingtonexaminer.com/resto…
1
4
12
1,336
Kevin Bardosh retweeted
1. 🔬 🔬 NIAID’s research mission has long focused on three areas: HIV, biodefense/pandemic preparedness, and all other infectious and immunologic diseases combined into one category. It’s time to refocus. nature.com/articles/s41591-0…
28
25
14
105
29,010
Kevin Bardosh retweeted
As a physician, scientist, & faculty member, I have been careful about speaking about hot button issues I spoke out during COVID about myocarditis & other issues I felt compelled to weigh in on the divide between academic elites vs science & public opinion on gender affirming care among minors iwfeatures.com/commentary/pu…
84
284
53
1,511
316,713
The official new Dietary Guidelines food pyramid Revolutionary. Grains now at the bottom
306
667
191
4,118
471,816
Starting 2026 by finishing a biography of Benjamin Franklin by @WalterIsaacson. I had no idea the guy was this hilarious & clever, especially his witty satirical propaganda. And his diplomatic skills (lol) playing the French/English off each other in the 1783 peace treaty -masterful (although America did not in the end acquire Canada, despite Franklin’s attempt).
1
3
272
Kevin Bardosh retweeted
Wow. This is an even more modest change than I had been led to believe. Why are public health experts' hair on fire over this? What is wrong with individualized shared decision-making, as we do in every other domain of medicine?
This is the language that was approved without modification at the recent ACIP meeting. Please read carefully for comprehension. Do not rely on press reports. Think for yourself. This wording is quite carefully nuanced.
33
47
5
237
21,124